BSE filing, BSE: 541444. Summary written from the filing by ALFA Finder's alert engine.
Palm Jewels Ltd: key numbers
- Share price
- ₹26.93
- Market cap
- ₹27.04 Cr
- Revenue (annual)
- ₹185.3 Cr
- Net profit (annual)
- ₹1.00 Cr
- P/E (TTM)
- 28.3×Sector 49.0×
- Promoter holding
- 43.36%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Palm Jewels Ltd
All →Palm Jewels Board Meeting Date
Palm Jewels will hold a board meeting on 30 October 2026 to consider unaudited quarterly results. The trading window reopens on 3 November 2026.
Palm Jewels Price Movement Clarification
Palm Jewels Limited clarified that recent share price movements are purely market-driven, confirming no pending price-sensitive information or announcements were withheld from the exchanges.
Palm Jewels Other Announcement
Palm Jewels Limited filed its quarterly Regulation 74(5) compliance certificate from its Registrar, KFin Technologies, for the period ending September 30, 2026.
Palm Jewels Annual General Meeting
Palm Jewels Ltd held its 21st Annual General Meeting on September 29, 2026. The meeting transacted ordinary business items as detailed in the AGM notice.
Palm Jewels Annual General Meeting
Palm Jewels Ltd has issued a notice for its Annual General Meeting scheduled for September 29, 2026. The agenda includes financial statements and director re-appointment.
Palm Jewels Annual Report
Palm Jewels Limited has submitted its Annual Report for the financial year 2025-26. The company also announced its Annual General Meeting scheduled for September 29, 2026.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.